February 2024
1. SCHNABL B
   PPAR Agonists in Primary Biliary Cholangitis.
   N Engl J Med. 2024;390:855-858.
   

   >> Share

   
   
2. HIRSCHFIELD GM, Bowlus CL, Mayo MJ, Kremer AE, et al
   A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
   N Engl J Med. 2024;390:783-794.
   

   >> Share

   
   
3. ASSIS DN
   Advancing Second-Line Treatment for Primary Biliary Cholangitis.
   N Engl J Med. 2024;390:853-854.
   

   >> Share

   
   
4. HARRISON SA, Bedossa P, Guy CD, Schattenberg JM, et al
   A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
   N Engl J Med. 2024;390:497-509.
   

   >> Share

   
   November 2023
5. ROBBINS J, Halegoua-DeMarzio D, Basu Mallick A, Vijayvergia N, et al
   Liver Transplantation in a Woman with Mahvash Disease.
   N Engl J Med. 2023;389:1972-1978.
   

   >> Share

   
   
6. KOWDLEY KV, Bowlus CL, Levy C, Akarca US, et al
   Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
   N Engl J Med. 2023 Nov 13. doi: 10.1056/NEJMoa2306185.
   

   >> Share

   
   February 2023
7. NADIM MK, Garcia-Tsao G
   Acute Kidney Injury in Patients with Cirrhosis.
   N Engl J Med. 2023;388:733-745.
   

   >> Share

   
   December 2022
8. BATALLER R, Arab JP, Shah VH
   Alcohol-Associated Hepatitis.
   N Engl J Med. 2022;387:2436-2448.
   

   >> Share

   
   August 2022
9. STRNAD P, Mandorfer M, Choudhury G, Griffiths W, et al
   Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency.
   N Engl J Med. 2022;387:514-524.
   

   >> Share

   
   January 2022
10. PATEL A, Tillman BF
    Spur-Cell Hemolytic Anemia.
    N Engl J Med. 2022;386:e6.
    

    >> Share

    
    October 2021
11. SANYAL AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, et al
    Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
    N Engl J Med. 2021;385:1559-1569.
    

    >> Share

    
    
12. FRANCQUE SM, Bedossa P, Ratziu V, Anstee QM, et al
    A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
    N Engl J Med. 2021;385:1547-1558.
    

    >> Share

    
    September 2021
13. CHANDRA A, Bhattacharjee MS
    Kayser-Fleischer Rings in Wilson's Disease.
    N Engl J Med. 2021;385:e46.
    

    >> Share

    
    
14. BAJAJ JS, Kamath PS, Reddy KR
    The Evolving Challenge of Infections in Cirrhosis. Reply.
    N Engl J Med. 2021;385:1151-1152.
    

    >> Share

    
    
15. HAIDAR G, Singh N
    The Evolving Challenge of Infections in Cirrhosis.
    N Engl J Med. 2021;385:1150-1151.
    

    >> Share

    
    June 2021
16. BAJAJ JS, Kamath PS, Reddy KR
    The Evolving Challenge of Infections in Cirrhosis.
    N Engl J Med. 2021;384:2317-2330.
    

    >> Share

    
    
17. WONG F, Curry MP, Sanyal AJ
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. Reply.
    N Engl J Med. 2021;384:e90.
    

    >> Share

    
    
18. CHINA L, Freemantle N, O'Brien A
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. Reply.
    N Engl J Med. 2021;384:e90.
    

    >> Share

    
    
19. RATHI S, Kalantri A, Kalantri S
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    

    >> Share

    
    
20. CHAUHAN A, Sharma S, Saraya A
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    

    >> Share

    
    
21. ELFEKI MA, O'Shea R, Carey WD
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    

    >> Share

    
    March 2021
22. CACOUB P, Saadoun D
    Extrahepatic Manifestations of Chronic HCV Infection.
    N Engl J Med. 2021;384:1038-1052.
    

    >> Share

    
    
23. GARCIA-TSAO G
    Terlipressin and Intravenous Albumin in Advanced Cirrhosis - Friend and Foe.
    N Engl J Med. 2021;384:869-871.
    

    >> Share

    
    
24. CHINA L, Freemantle N, Forrest E, Kallis Y, et al
    A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:808-817.
    

    >> Share

    
    
25. WONG F, Pappas SC, Curry MP, Reddy KR, et al
    Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
    N Engl J Med. 2021;384:818-828.
    

    >> Share

    
    November 2020
26. NEWSOME PN, Buchholtz K, Cusi K, Linder M, et al
    A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2028395.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share